← Browse by Condition
Medical Condition
eczema
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 3
NCT05938478
Recruiting
Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
Enrollment
900 pts
Location
United States
Sponsor
University of California, San ...
NCT07037901 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Enrollment
220 pts
Location
United States, Canad...
Sponsor
Inmagene LLC
NCT06807268 Phase 3
Recruiting
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Enrollment
150 pts
Location
United States, China...
Sponsor
Pfizer